arrow
N

Nanda Aryal

Australian Institute of Health Innovation
H指数:7
被引数:272

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementation evaluation of nurse-initiated care in 29 Australian emergency departments: a RE-AIM multi-method evaluation

护士发起的护理在29家澳大利亚急诊科的实施方案评估:一项RE-AIM多方法评估

2026-07-130
OA
Effectiveness of computerised alerts to reduce drug-drug interactions (DDIs) and DDI-related harm in hospitalised patients: a quasi-experimental controlled pre-post study

计算机化警报在减少住院患者药物-药物相互作用(DDIs)及DDI相关损害中的有效性:一项准实验性对照前后对照研究

2025-05-110
PRE
Identifying Barriers and Enablers for Nurse-Initiated Care for Designing Implementation at Scale in Australian Emergency Departments: A Mixed Methods Study

在澳大利亚急诊科大规模设计实施护士启动护理的障碍和推动因素: 一项混合方法研究

2025-02-190
OA
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial
2022-10-0169
OAAI
Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy

预测2型糖尿病中威胁视力的糖尿病视网膜病变的视网膜病变风险计算器: 一项现场子研究

2022-04-014
PRE
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study

尿酸可预测2型糖尿病的长期心血管风险,但不能介导非诺贝特的益处: FIELD研究

2020-04-2210
PREAI